McKesson Ventures came onboard for the health data provider Evidation's series D round, helping it hike its overall funding to $106m five years after being co-founded by Stanford Health Care.
US-based health data provider Evidation Health completed a $45m series D round on Wednesday that included McKesson Ventures, the strategic investment arm of healthcare product distributor McKesson.
The round was led by venture capital firm B Capital Group and also featured Section 32, Revelation Partners, Rethink Impact and SV Health Investors. It increased the company’s funding to $106m since it was founded in 2012.
Evidation has created a software platform that passively collects data on everyday behaviour from sources like electronic devices, sensors, speech or video, and analyses it to generate insights and support research that could lead to improving healthcare.
It was launched in March 2015 through a partnership between GE Ventures and Stanford Health Care, the academic health system of Stanford University.
The company raised $30m in an August 2018 series C round co-led by B Capital Group and SV Health Investors…
